Login / Signup

Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trial.

Lara ZafraniEmmanuel CanetAnouk Walter-PetrichBérangère Joly-LaffargueAgnès VeyradierStanislas FaguerNaïke BigéLaure CalvetJulien MayauxSteven GrangéCédric RafatCoralie PoulainKada KlouchePierre PerezFrédéric PèneClaire PichereauBaptiste DuceauEric MariotteSylvie ChevretElie Azoulay
Published in: Intensive care medicine (2023)
Among patients with TTP, the addition of magnesium sulphate to the standard of care did not result in a significant improvement in time to platelet normalisation.
Keyphrases
  • double blind
  • clinical trial
  • phase iii
  • placebo controlled
  • study protocol
  • phase ii
  • open label
  • healthcare
  • palliative care
  • randomized controlled trial
  • quality improvement
  • pain management
  • health insurance
  • chronic pain